Herbal medicine safety under the microscope in korean hospitals
NCT ID NCT04269486
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study observed women aged 19–80 who were hospitalized for at least two weeks and taking herbal medicines. Researchers tracked liver and kidney function through regular blood tests to see if any injuries occurred. The goal was to better understand the safety profile of these commonly used herbs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
287 people
The number who actually took part.
- Started
-
Jul 2019
- Finished
-
Dec 2024
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The female inpatients who showed their autonomy and voluntarily signed informed consent on the observations thorughout hospitalization period.
- Ages
-
19 to 80 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female whose age is between 19 and 80 * Inpatient expected to stay at least 2 weeks and to intake herbal medicine * Who signed voluntarily informed consent. Exclusion Criteria: * Who were short of stay for 2 weeks or stopped intaking herbal medicine * Who had problems physically or mentally by investigator
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Drug induced liver injury are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Five tertiary Korean Medicine Hospital (Jecheon, Yangsan, Gwangju, Seoul, Bundang)
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may solve tricky liver diagnosis puzzle
- New study aims to uncover the impact of itching in liver injury patients
- Massive study tracks hidden liver dangers of common drugs and herbal remedies
- New study collects data and samples to unlock mysteries of Drug-Induced liver damage
- Blood cancer patients may get liver protection from common drug
- Milk thistle extract may help repair Medication-Damaged livers